These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 22216531)

  • 1. Improved fluorimetric assay of plasma propranolol.
    Offerhaus L; van der Vecht JR
    Br J Clin Pharmacol; 1976 Dec; 3(6):1061-2. PubMed ID: 22216531
    [No Abstract]   [Full Text] [Related]  

  • 2. Two reproducible and sensitive liquid chromatographic methods to quantify atenolol and propranolol in human plasma and determination of their associated analytical error functions.
    Braza AJ; Modamio P; Mariño EL
    J Chromatogr B Biomed Sci Appl; 2000 Feb; 738(2):225-31. PubMed ID: 10718640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A fluorimetric liquid chromatographic method for the determination of propranolol in human serum/plasma.
    Rekhi GS; Jambhekar SS; Souney PF; Williams DA
    J Pharm Biomed Anal; 1995 Nov; 13(12):1499-505. PubMed ID: 8788135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of cimetidine with metoprolol, propranolol, or atenolol.
    Kirch W; Köhler H; Spahn H; Mutschler E
    Lancet; 1981 Sep; 2(8245):531-2. PubMed ID: 6115283
    [No Abstract]   [Full Text] [Related]  

  • 5. Stereoselective high-performance liquid chromatography determination of propranolol and 4-hydroxypropranolol in human plasma after pre-column derivatization.
    Wu ST; Chang YP; Gee WL; Benet LZ; Lin ET
    J Chromatogr B Biomed Sci Appl; 1997 Apr; 692(1):133-40. PubMed ID: 9187392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exercise increases plasma concentrations of (R)- and (S)-propranolol.
    Stoschitzky K; Schumacher M; Stark G; Dimai HP; Stauber R; Stoschitzky P; Krejs GJ; Klein W; Lindner W
    Eur J Clin Pharmacol; 1996; 50(4):339-42. PubMed ID: 8803530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of route of administration on the relationship between -adrenergic blockade and plasma propranolol level.
    Cleaveland CR; Shand DG
    Clin Pharmacol Ther; 1972; 13(2):181-5. PubMed ID: 4401564
    [No Abstract]   [Full Text] [Related]  

  • 8. A simple, sensitive and specific radioreceptor assay for beta-adrenergic antagonist drugs.
    Innis RB; Bylund DB; Snyder SH
    Life Sci; 1978 Nov; 23(20):2031-7. PubMed ID: 31538
    [No Abstract]   [Full Text] [Related]  

  • 9. Determination of the new beta-blocker bisoprolol and of metoprolol, atenolol and propranolol in plasma and urine by high-performance liquid chromatography.
    Bühring KU; Garbe A
    J Chromatogr; 1986 Oct; 382():215-24. PubMed ID: 2878004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of kinetic interactions of nadolol and propranolol with cimetidine.
    Duchin KL; Stern MA; Willard DA; McKinstry DN
    Am Heart J; 1984 Oct; 108(4 Pt 2):1084-6. PubMed ID: 6148867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase in plasma propranolol caused by nicardipine is dependent on the delivery rate of propranolol.
    Vercruysse I; Massart DL; Dupont AG
    Eur J Clin Pharmacol; 1995; 49(1-2):121-5. PubMed ID: 8751033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma concentration and antihypertensive effect of beta-receptor blockers.
    Hitzenberger G
    Cardiology; 1979; 64 Suppl 1():14-9. PubMed ID: 42485
    [No Abstract]   [Full Text] [Related]  

  • 13. Binding of adrenergic beta-receptor antagonists to human serum albumin.
    Appelgren C; Borg KO; Elofsson R; Johansson KA
    Acta Pharm Suec; 1974 Sep; 11(4):325-32. PubMed ID: 4153285
    [No Abstract]   [Full Text] [Related]  

  • 14. [Study of the binding of beta blockers to plasma proteins. Therapeutic consequences].
    Decourt S; Roux A; Baglin A; Domart M; Aubert P; Flouvat B; Fritel D
    Acquis Med Recent; 1977; ():181-94. PubMed ID: 20725
    [No Abstract]   [Full Text] [Related]  

  • 15. Dynamic and kinetic comparison of penbutolol and propranolol in healthy volunteers [proceedings].
    Baird IM; Hill H; Ings RM; Johnson KI; McEwen J
    Br J Clin Pharmacol; 1977 Jun; 4(3):386P. PubMed ID: 20121
    [No Abstract]   [Full Text] [Related]  

  • 16. A radioreceptor assay in which iodocyanopindolol is used to determine propranolol and its active metabolites in unextracted serum or plasma.
    Elkins RP; Kelly JF; Rosenberg BJ
    Clin Chem; 1986 Jan; 32(1 Pt 1):180-3. PubMed ID: 2866853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcohol withdrawal changes cardiovascular responses to propranolol challenge.
    Kähkönen S
    Neuropsychobiology; 2003; 47(4):192-7. PubMed ID: 12824742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereoselective binding of beta-blockers to purified rat alpha 1-acid glycoprotein.
    Murai-Kushiya M; Okada S; Kimura T; Hasegawa R
    J Pharm Pharmacol; 1993 Mar; 45(3):225-8. PubMed ID: 8097783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propranolol safety profile in children.
    El-Shabrawi M; Hassanin F
    Curr Drug Saf; 2011 Sep; 6(4):259-66. PubMed ID: 22129321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of inflammatory disease on plasma concentrations of three beta-adrenoceptor blocking agents.
    Schneider RE; Bishop H; Kendall MJ; Quarterman CP
    Int J Clin Pharmacol Ther Toxicol; 1981 Apr; 19(4):158-62. PubMed ID: 6114930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.